[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362904-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362904-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","distinct-gut-virome-profiles-are-associated-with-response-to-anti-pd-1-therapy-in-nonsmall-cell-lung-cancer","Distinct gut virome profiles are associated with response to anti-PD-1 therapy in nonsmall cell lung cancer","","Research in advanced non–small cell lung cancer shows that gut microbiota can modulate immune checkpoint inhibitor (ICI) efficacy, but the role of the gut virome is not well characterized. This study profiles fecal viromes from 338 treated patients and tests generalizability in an external cohort of 30. Viral diversity, community structure, differential vOTUs, virus–bacteria networks, and functional signatures are linked to clinical response, outperforming bacterium-based predictors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/distinct-gut-virome-profiles-are-associated-with-response-to-anti-pd-1-therapy-in-nonsmall-cell-lung-cancer/362904/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/distinct-gut-virome-profiles-are-associated-with-response-to-anti-pd-1-therapy-in-nonsmall-cell-lung-cancer/362904.png","ImageObject",300,407,{"name":42,"@type":43},"Melati","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main goal regarding the gut virome?","Question",{"text":63,"@type":64},"To characterize gut virome features and evaluate how they may shape response to PD-1 blockade in advanced NSCLC.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were viral profiles linked to treatment response in this research?",{"text":68,"@type":64},"By analyzing viral diversity, community structures between responders and non-responders, differential vOTUs, virus–bacteria co-occurrence networks, and functional potential.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about prediction performance for response?",{"text":72,"@type":64},"A virus-only random forest model predicted response better than a bacterium-only model, and it retained stronger performance in an external cohort.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362904,1790577404,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Liu et al. Journal of Translational Medicine (2026) 24:461  \n[https://doi.org/10.1186/s12967-026-07900-0](https://doi.org/10.1186/s12967-026-07900-0)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nDistinct gut virome profiles are associated with response to anti-PD-1 therapy in nonsmall cell lung cancer  \nZhuo Liu1†, Meihong Liu1†, Huixiang Chen2†, Shenghui Li2,3, Ning Zheng4, Guorui Xing2, Yue Zhang2, Jie Xu2, Min Li2, Chenghaotian Xiao3, Tong Lu4, Qiulong Yan4, Zhixin Lei3,5,6*, Min Feng1* and Yanxia Li 1*  \nAbstract  \nBackground The gut microbiota is a key modulator of immune checkpoint inhibitor (ICI) efficacy, yet the contribution of the gut virome remains poorly defined, particularly in advanced non–small cell lung cancer (NSCLC) . Here, we characterized the gut virome and explored its potential role in shaping response to PD-1 blockade. Methods We performed metagenomic virome profiling of fecal samples from 338 advanced NSCLC patients treated with PD-1 inhibitors and evaluated model generalizability in an independent external cohort (n = 30) . Viral diversity, taxonomic composition, and functional potential were analyzed. Virus–bacteria co-occurrence networks were constructed, and random forest classifiers were developed to predict treatment response.  \nResults Viral Shannon diversity decreased progressively with poorer clinical response, and β-diversity analyses revealed distinct virome community structures between responders (R) and non-responders (NR) . Differential abundance analysis identified 194 NR-enriched vOTUs, predominantly assigned to Peduoviridae and Inoviridae, and 594 R-enriched vOTUs, mainly from Herelleviridae and Microviridae. Host prediction indicated that NR-enriched vOTUs frequently targeted bacterial genera such as Clostridium_M, Bacteroides, and Escherichia, whereas R-enriched vOTUs targeted beneficial genera such as Faecalibacterium and Roseburia. Network analyses further revealed responsespecific virus–bacteria interaction modules. Functional profiling showed that NR-enriched vOTUs were associated with metabolic functions, including K01689 (eno; enolase) . A virus-only random forest model outperformed a bacterium-only model in predicting response (area under the curve [AUC] = 0.768 vs. 0. 664) and maintained superior performance in the external cohort (AUC = 0 . 742) . In addition, Akkermansia muciniphila positivity was associated with a higher-diversity, responder-favorable virome configuration.  \n†These authors contributed equally to this work.  \n*Correspondence:  \nZhixin Lei [leizhixin@whut.edu.cn](leizhixin@whut.edu.cn)[ ](leizhixin@whut.edu.cn)Min Feng [fengfeng0716@163.com](fengfeng0716@163.com)[ ](fengfeng0716@163.com)Yanxia Li[liyanxia001@163.com](liyanxia001@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLiu et a","cbCaipPUBc1nix1k","https://ap.wps.com/l/cbCaipPUBc1nix1k","pdf",10392812,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the study’s main goal regarding the gut virome?\",\"answer\":\"To characterize gut virome features and evaluate how they may shape response to PD-1 blockade in advanced NSCLC.\"},{\"question\":\"How were viral profiles linked to treatment response in this research?\",\"answer\":\"By analyzing viral diversity, community structures between responders and non-responders, differential vOTUs, virus–bacteria co-occurrence networks, and functional potential.\"},{\"question\":\"What did the study find about prediction performance for response?\",\"answer\":\"A virus-only random forest model predicted response better than a bacterium-only model, and it retained stronger performance in an external cohort.\"}]","Distinct gut virome profiles are associated with response to anti-PD-1 therapy in nonsmall cell lung cancer | PDF",1790149386,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/082f9d020364fd60727495accd03c376.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfc1f3ee837a485b5be941a8d384bb92.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31dbfa734b6ff1ba8b597980c8bdeca2.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ed872c22c1c1db64efbdd644eb8b7f8.webp",980,1306]